array(40) {
  [0]=>
  string(4) "8545"
  ["article_id"]=>
  string(4) "8545"
  [1]=>
  string(46) "Welsh Pharmacy Board meeting: 5 February 2020 "
  ["article_title"]=>
  string(46) "Welsh Pharmacy Board meeting: 5 February 2020 "
  [2]=>
  string(150) "At the latest Royal Pharmaceutical Society Welsh Pharmacy Board meeting, discussions revolved around Brexit, medicines shortages and public affairs in"
  ["short_description"]=>
  string(150) "At the latest Royal Pharmaceutical Society Welsh Pharmacy Board meeting, discussions revolved around Brexit, medicines shortages and public affairs in"
  [3]=>
  string(157) "At the latest Royal Pharmaceutical Society Welsh Pharmacy Board meeting, discussions revolved around Brexit, medicines shortages and public affairs in Wales."
  ["description"]=>
  string(157) "At the latest Royal Pharmaceutical Society Welsh Pharmacy Board meeting, discussions revolved around Brexit, medicines shortages and public affairs in Wales."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(109) "https://www.pharmaceutical-journal.com/your-rps/welsh-pharmacy-board-meeting-5-february-2020/20207728.article"
  ["blog_url"]=>
  string(109) "https://www.pharmaceutical-journal.com/your-rps/welsh-pharmacy-board-meeting-5-february-2020/20207728.article"
  [15]=>
  string(19) "2020-03-24 23:25:00"
  ["add_date"]=>
  string(19) "2020-03-24 23:25:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:18:02"
  ["create_at"]=>
  string(19) "2020-03-31 11:18:02"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8548"
  ["article_id"]=>
  string(4) "8548"
  [1]=>
  string(60) "Case-based learning: management of polycystic ovary syndrome"
  ["article_title"]=>
  string(60) "Case-based learning: management of polycystic ovary syndrome"
  [2]=>
  string(150) "As the most common incurable hormonal condition affecting women of reproductive age, polycystic ovary syndrome can lead to infertility, anxiety and ca"
  ["short_description"]=>
  string(150) "As the most common incurable hormonal condition affecting women of reproductive age, polycystic ovary syndrome can lead to infertility, anxiety and ca"
  [3]=>
  string(206) "As the most common incurable hormonal condition affecting women of reproductive age, polycystic ovary syndrome can lead to infertility, anxiety and cardiovascular disease if it is not managed appropriately."
  ["description"]=>
  string(206) "As the most common incurable hormonal condition affecting women of reproductive age, polycystic ovary syndrome can lead to infertility, anxiety and cardiovascular disease if it is not managed appropriately."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "12"
  ["rss_id"]=>
  string(2) "12"
  [14]=>
  string(149) "https://www.pharmaceutical-journal.com/cpd-and-learning/learning-article/case-based-learning-management-of-polycystic-ovary-syndrome/20207804.article"
  ["blog_url"]=>
  string(149) "https://www.pharmaceutical-journal.com/cpd-and-learning/learning-article/case-based-learning-management-of-polycystic-ovary-syndrome/20207804.article"
  [15]=>
  string(19) "2020-03-24 23:14:00"
  ["add_date"]=>
  string(19) "2020-03-24 23:14:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:18:04"
  ["create_at"]=>
  string(19) "2020-03-31 11:18:04"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8656"
  ["article_id"]=>
  string(4) "8656"
  [1]=>
  string(68) "IPA World Congress + Probiota Americas 2020 postponed until November"
  ["article_title"]=>
  string(68) "IPA World Congress + Probiota Americas 2020 postponed until November"
  [2]=>
  string(150) "In light of the ongoing novel Coronavirus (COVID19) public health emergency, IPA World Congress + Probiota Americas has been postponed until November "
  ["short_description"]=>
  string(150) "In light of the ongoing novel Coronavirus (COVID19) public health emergency, IPA World Congress + Probiota Americas has been postponed until November "
  [3]=>
  string(215) "In light of the ongoing novel Coronavirus (COVID19) public health emergency, IPA World Congress + Probiota Americas has been postponed until November 16-18, 2020 at the Crystal Gateway Marriott Hotel, Washington DC."
  ["description"]=>
  string(215) "In light of the ongoing novel Coronavirus (COVID19) public health emergency, IPA World Congress + Probiota Americas has been postponed until November 16-18, 2020 at the Crystal Gateway Marriott Hotel, Washington DC."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(174) "https://www.nutraingredients-usa.com/Article/2020/03/24/IPA-World-Congress-Probiota-Americas-2020-postponed-until-November?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(174) "https://www.nutraingredients-usa.com/Article/2020/03/24/IPA-World-Congress-Probiota-Americas-2020-postponed-until-November?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-24 23:00:00"
  ["add_date"]=>
  string(19) "2020-03-24 23:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:33"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8699"
  ["article_id"]=>
  string(4) "8699"
  [1]=>
  string(76) "Research suggests graphite nanoplatelets can protect devices from infections"
  ["article_title"]=>
  string(76) "Research suggests graphite nanoplatelets can protect devices from infections"
  [2]=>
  string(150) "According to research from Chalmers University of Technology in Sweden, graphite nanoplatelets integrated into plastic medical surfaces can prevent in"
  ["short_description"]=>
  string(150) "According to research from Chalmers University of Technology in Sweden, graphite nanoplatelets integrated into plastic medical surfaces can prevent in"
  [3]=>
  string(209) "According to research from Chalmers University of Technology in Sweden, graphite nanoplatelets integrated into plastic medical surfaces can prevent infections by killing 99.99% of bacteria which try to attach."
  ["description"]=>
  string(209) "According to research from Chalmers University of Technology in Sweden, graphite nanoplatelets integrated into plastic medical surfaces can prevent infections by killing 99.99% of bacteria which try to attach."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(59) "https://www.medicalplasticsnews.com/news/research-suggests/"
  ["blog_url"]=>
  string(59) "https://www.medicalplasticsnews.com/news/research-suggests/"
  [15]=>
  string(19) "2020-03-24 22:41:26"
  ["add_date"]=>
  string(19) "2020-03-24 22:41:26"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8700"
  ["article_id"]=>
  string(4) "8700"
  [1]=>
  string(64) "How to cope with the increasing popularity of wearable injectors"
  ["article_title"]=>
  string(64) "How to cope with the increasing popularity of wearable injectors"
  [2]=>
  string(154) "Manuel Scherer, business development manager, Europe in the healthcare segment of Sabic's specialties business looks at whether the advent of wearable"
  ["short_description"]=>
  string(154) "Manuel Scherer, business development manager, Europe in the healthcare segment of Sabic's specialties business looks at whether the advent of wearable"
  [3]=>
  string(205) "Manuel Scherer, business development manager, Europe in the healthcare segment of Sabic's specialties business looks at whether the advent of wearable injectors calls for a more collaborative approach."
  ["description"]=>
  string(205) "Manuel Scherer, business development manager, Europe in the healthcare segment of Sabic's specialties business looks at whether the advent of wearable injectors calls for a more collaborative approach."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(47) "https://www.medicalplasticsnews.com/news/sabic/"
  ["blog_url"]=>
  string(47) "https://www.medicalplasticsnews.com/news/sabic/"
  [15]=>
  string(19) "2020-03-24 22:00:46"
  ["add_date"]=>
  string(19) "2020-03-24 22:00:46"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8723"
  ["article_id"]=>
  string(4) "8723"
  [1]=>
  string(48) "WCG launches COVID-19 clinical research webinars"
  ["article_title"]=>
  string(48) "WCG launches COVID-19 clinical research webinars"
  [2]=>
  string(130) "The informational series, featuring guest panelists and company leaders, will focus on best practices in the face of the pandemic."
  ["short_description"]=>
  string(130) "The informational series, featuring guest panelists and company leaders, will focus on best practices in the face of the pandemic."
  [3]=>
  string(130) "The informational series, featuring guest panelists and company leaders, will focus on best practices in the face of the pandemic."
  ["description"]=>
  string(130) "The informational series, featuring guest panelists and company leaders, will focus on best practices in the face of the pandemic."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(160) "https://www.outsourcing-pharma.com/Article/2020/03/24/Webinars-address-coronavirus-impact-on-clinical-trials?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(160) "https://www.outsourcing-pharma.com/Article/2020/03/24/Webinars-address-coronavirus-impact-on-clinical-trials?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-24 21:37:00"
  ["add_date"]=>
  string(19) "2020-03-24 21:37:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:44"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8724"
  ["article_id"]=>
  string(4) "8724"
  [1]=>
  string(44) "PolarisQB, Fujitsu partner on drug discovery"
  ["article_title"]=>
  string(44) "PolarisQB, Fujitsu partner on drug discovery"
  [2]=>
  string(141) "The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases."
  ["short_description"]=>
  string(141) "The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases."
  [3]=>
  string(141) "The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases."
  ["description"]=>
  string(141) "The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(149) "https://www.outsourcing-pharma.com/Article/2020/03/24/PolarisQB-Fujitsu-partner-on-drug-discovery?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(149) "https://www.outsourcing-pharma.com/Article/2020/03/24/PolarisQB-Fujitsu-partner-on-drug-discovery?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-24 21:02:00"
  ["add_date"]=>
  string(19) "2020-03-24 21:02:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:44"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8739"
  ["article_id"]=>
  string(4) "8739"
  [1]=>
  string(84) "&#nlCOVID-19: Beware of falsified medicines from unregistered websites, , 24/03/2020"
  ["article_title"]=>
  string(84) "&#nlCOVID-19: Beware of falsified medicines from unregistered websites, , 24/03/2020"
  [2]=>
  string(159) "&#nl&#nl          &#nl              EMA is urging the general public not to buy medicines from unauthorised websites and other vendors aiming to exploit fears "
  ["short_description"]=>
  string(159) "&#nl&#nl          &#nl              EMA is urging the general public not to buy medicines from unauthorised websites and other vendors aiming to exploit fears "
  [3]=>
  string(185) "&#nl&#nl          &#nl              EMA is urging the general public not to buy medicines from unauthorised websites and other vendors aiming to exploit fears and concerns during the..."
  ["description"]=>
  string(185) "&#nl&#nl          &#nl              EMA is urging the general public not to buy medicines from unauthorised websites and other vendors aiming to exploit fears and concerns during the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "88"
  ["rss_id"]=>
  string(2) "88"
  [14]=>
  string(92) "
https://www.ema.europa.eu/en/news/covid-19-beware-falsified-medicines-unregistered-websites"
  ["blog_url"]=>
  string(92) "
https://www.ema.europa.eu/en/news/covid-19-beware-falsified-medicines-unregistered-websites"
  [15]=>
  string(19) "2020-03-24 21:00:00"
  ["add_date"]=>
  string(19) "2020-03-24 21:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:24:06"
  ["create_at"]=>
  string(19) "2020-03-31 11:24:06"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8601"
  ["article_id"]=>
  string(4) "8601"
  [1]=>
  string(129) "Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer"
  ["article_title"]=>
  string(129) "Exagen Appoints Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer, and Anja Kammesheidt, Ph.D., as Chief Scientific Officer"
  [2]=>
  string(154) "SAN DIEGO, March  24, 2020  (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients"
  ["short_description"]=>
  string(154) "SAN DIEGO, March  24, 2020  (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients"
  [3]=>
  string(627) "
SAN DIEGO, March  24, 2020  (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced the appointment of Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer (CMO), and Anja Kammesheidt, Ph.D., as Chief Scientific Officer (CSO).  The addition of Drs. Zack and Kammesheidt to the Exagen team will strengthen the company as it continues to focus on clinical research and development initiatives to serve the needs of healthcare providers and their patients.
"
  ["description"]=>
  string(627) "
SAN DIEGO, March  24, 2020  (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced the appointment of Debra Jeske Zack, M.D., Ph.D., as Chief Medical Officer (CMO), and Anja Kammesheidt, Ph.D., as Chief Scientific Officer (CSO).  The addition of Drs. Zack and Kammesheidt to the Exagen team will strengthen the company as it continues to focus on clinical research and development initiatives to serve the needs of healthcare providers and their patients.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(191) "http://www.globenewswire.com/news-release/2020/03/24/2005493/0/en/Exagen-Appoints-Debra-Jeske-Zack-M-D-Ph-D-as-Chief-Medical-Officer-and-Anja-Kammesheidt-Ph-D-as-Chief-Scientific-Officer.html"
  ["blog_url"]=>
  string(191) "http://www.globenewswire.com/news-release/2020/03/24/2005493/0/en/Exagen-Appoints-Debra-Jeske-Zack-M-D-Ph-D-as-Chief-Medical-Officer-and-Anja-Kammesheidt-Ph-D-as-Chief-Scientific-Officer.html"
  [15]=>
  string(19) "2020-03-24 20:25:00"
  ["add_date"]=>
  string(19) "2020-03-24 20:25:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:19"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:19"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8725"
  ["article_id"]=>
  string(4) "8725"
  [1]=>
  string(61) "Data management tech aims to double COVID-19 testing capacity"
  ["article_title"]=>
  string(61) "Data management tech aims to double COVID-19 testing capacity"
  [2]=>
  string(148) "Technology company Ovation has launched an initiative involving its laboratory information management system designed to expand capacity nationwide."
  ["short_description"]=>
  string(148) "Technology company Ovation has launched an initiative involving its laboratory information management system designed to expand capacity nationwide."
  [3]=>
  string(148) "Technology company Ovation has launched an initiative involving its laboratory information management system designed to expand capacity nationwide."
  ["description"]=>
  string(148) "Technology company Ovation has launched an initiative involving its laboratory information management system designed to expand capacity nationwide."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(152) "https://www.outsourcing-pharma.com/Article/2020/03/24/LIMS-technology-to-double-coronavirus-capacity?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(152) "https://www.outsourcing-pharma.com/Article/2020/03/24/LIMS-technology-to-double-coronavirus-capacity?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-24 20:21:00"
  ["add_date"]=>
  string(19) "2020-03-24 20:21:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:44"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8527"
  ["article_id"]=>
  string(4) "8527"
  [1]=>
  string(135) "FDA Alerts Patients and Health Care Professionals of EpiPen Auto-Injector Errors Related to Device Malfunctions and User Administration"
  ["article_title"]=>
  string(135) "FDA Alerts Patients and Health Care Professionals of EpiPen Auto-Injector Errors Related to Device Malfunctions and User Administration"
  [2]=>
  string(150) "Audience: Patients, Caregivers,  Health Care Professionals March 24, 2020 -- FDA is alerting patients, caregivers and health care professionals that E"
  ["short_description"]=>
  string(150) "Audience: Patients, Caregivers,  Health Care Professionals March 24, 2020 -- FDA is alerting patients, caregivers and health care professionals that E"
  [3]=>
  string(242) "Audience: Patients, Caregivers,  Health Care Professionals March 24, 2020 -- FDA is alerting patients, caregivers and health care professionals that EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may..."
  ["description"]=>
  string(242) "Audience: Patients, Caregivers,  Health Care Professionals March 24, 2020 -- FDA is alerting patients, caregivers and health care professionals that EpiPen 0.3mg and EpiPen Jr 0.15mg auto-injectors, and the authorized generic versions, may..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(300) "https://www.drugs.com/fda/fda-alerts-patients-health-care-professionals-epipen-auto-injector-errors-related-device-14354.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Alerts+Patients+and+Health+Care+Professionals+of+EpiPen+Auto-Injector+Errors+Related+to+Device+Malfunctions+and+User+Administra"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/fda/fda-alerts-patients-health-care-professionals-epipen-auto-injector-errors-related-device-14354.html?utm_source=ddc&utm_medium=rss&utm_campaign=FDA+Alerts+Patients+and+Health+Care+Professionals+of+EpiPen+Auto-Injector+Errors+Related+to+Device+Malfunctions+and+User+Administra"
  [15]=>
  string(19) "2020-03-24 20:00:00"
  ["add_date"]=>
  string(19) "2020-03-24 20:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:17:59"
  ["create_at"]=>
  string(19) "2020-03-31 11:17:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8701"
  ["article_id"]=>
  string(4) "8701"
  [1]=>
  string(56) "New medical device supplier receives £650k investment"
  ["article_title"]=>
  string(56) "New medical device supplier receives £650k investment"
  [2]=>
  string(157) "North Yorkshire-based, GI UK Medical, has secured a £650,000 investment from NPIF – Mercia Equity Finance, which is managed by Mercia and part of t"
  ["short_description"]=>
  string(157) "North Yorkshire-based, GI UK Medical, has secured a £650,000 investment from NPIF – Mercia Equity Finance, which is managed by Mercia and part of t"
  [3]=>
  string(196) "North Yorkshire-based, GI UK Medical, has secured a £650,000 investment from NPIF – Mercia Equity Finance, which is managed by Mercia and part of the Northern Powerhouse Investment Fund."
  ["description"]=>
  string(196) "North Yorkshire-based, GI UK Medical, has secured a £650,000 investment from NPIF – Mercia Equity Finance, which is managed by Mercia and part of the Northern Powerhouse Investment Fund."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(95) "https://www.medicalplasticsnews.com/news/new-medical-devices-supplier-receives-650k-investment/"
  ["blog_url"]=>
  string(95) "https://www.medicalplasticsnews.com/news/new-medical-devices-supplier-receives-650k-investment/"
  [15]=>
  string(19) "2020-03-24 19:10:00"
  ["add_date"]=>
  string(19) "2020-03-24 19:10:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}